Imperial College London

Professor Nicholas Simmonds

Faculty of MedicineNational Heart & Lung Institute

Professor of Practice (Respiratory Medicine)
 
 
 
//

Contact

 

+44 (0)20 7351 8997n.simmonds

 
 
//

Location

 

Dept of Cystic FibrosisRoyal BromptonRoyal Brompton Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Van:2021:10.1186/s13063-021-05457-5,
author = {Van, Koningsbruggen-Rietschel S and Dunlevy, F and Bulteel, V and Hayes, K and Verbrugge, A and Janssens, HM and Dufeu, N and Simmonds, NJ and Dupont, LJ and Downey, DG},
doi = {10.1186/s13063-021-05457-5},
journal = {TRIALS},
title = {Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measures},
url = {http://dx.doi.org/10.1186/s13063-021-05457-5},
volume = {22},
year = {2021}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AU - Van,Koningsbruggen-Rietschel S
AU - Dunlevy,F
AU - Bulteel,V
AU - Hayes,K
AU - Verbrugge,A
AU - Janssens,HM
AU - Dufeu,N
AU - Simmonds,NJ
AU - Dupont,LJ
AU - Downey,DG
DO - 10.1186/s13063-021-05457-5
PY - 2021///
TI - Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measures
T2 - TRIALS
UR - http://dx.doi.org/10.1186/s13063-021-05457-5
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000690960300004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL - 22
ER -